MALVERN, Pa., Jan. 31, 2025 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical ...
By raising ₹500-600 crore, this firm aims to strengthen its market position and adapt to evolving global trends.
MicroStrategy has announced the pricing of its strike preferred stock offering as the company continues to finance Bitcoin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback